Pfizer Weight Loss Drug Shows Promise in Trial
Pfizer's experimental monthly weight loss injection demonstrates significant efficacy in mid-stage clinical trial, with participants losing up to 12.3% body weight over 28 weeks.
Category : Pharmaceuticals
Ozempic and Mounjaro: Readers Share Side Effect Experiences
Independent readers discuss the severe side effects of GLP-1 drugs like Ozempic and Mounjaro, with many questioning if risks are fully acknowledged as use grows.
Ozempic and Mounjaro Side Effects: Readers' Mixed Views
Independent readers discuss the severe side effects of GLP-1 drugs like Ozempic and Mounjaro, with many questioning if risks are fully acknowledged as usage grows.
Energy Supplement Recalled Over Undeclared Drug
Akkarco LLC recalls Ashfiat Alharamain Energy Support after FDA testing reveals contamination with Tadalafil, posing serious health risks to consumers.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Novo Nordisk Shares Plunge 20% on 2026 Outlook Warning
Danish pharmaceutical giant Novo Nordisk sees shares plummet nearly 20% after forecasting sales and earnings declines for 2026, while rival Eli Lilly reports surging profits from weight loss drug Mounjaro.
GSK Profits Rise but 2026 Growth to Slow Under New CEO
Pharmaceutical giant GSK posts 7% profit increase for 2025 driven by HIV and asthma treatments, but warns of moderating growth in 2026 under new CEO Luke Miels.
Wegovy and Ozempic Revenue Forecasts Cut, Novo Nordisk Shares Drop
Novo Nordisk has revised down its revenue forecasts for blockbuster drugs Wegovy and Ozempic, leading to a sharp decline in its share price amid market concerns.
Mother shares Wegovy pill success after injection costs too high
Sharon Vickers, 46, from South Carolina, turned to the new Wegovy oral medication after finding GLP-1 injections unaffordable at $500 monthly, achieving weight loss breakthrough.
GSK Profits Rise but 2026 Growth to Slow
Pharmaceutical giant GSK reveals increased profits driven by HIV and asthma treatments, but warns of moderating growth in 2026 under new CEO Luke Miels.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Lawmaker Raises Concerns Over FDA Fast-Track Drug Program
A Democratic congressman has issued fresh criticism regarding the FDA's accelerated drug review scheme, questioning its transparency, legal authority, and potential ethical conflicts among senior officials involved in the process.
Mounjaro Reactions Spike 340% in UK with 71 Deaths
MHRA data reveals alarming 340% increase in adverse reactions to weight loss drug Mounjaro, with 71 fatalities recorded in 2025. Gastrointestinal disorders dominate reports as patient stories highlight severe side effects.
Cancer and Stroke Drugs Among 400 UK Medicines at Risk
NHS England identifies 378 medicines with single or no suppliers, threatening treatments for cancer, stroke and schizophrenia. A new scheme aims to incentivise manufacturers.
Girl Overdoses on Mother's GLP-1 Weight Loss Medication
An eight-year-old girl from Indiana was hospitalised after injecting herself with her mother's GLP-1 medication, suffering severe symptoms and highlighting safety concerns.
GLP-1 Drugs Reshape Food, Fashion, Travel & Beverage Industries
Weight loss medications like Ozempic and Wegovy are causing seismic shifts across multiple sectors, reducing spending on groceries and fast food while impacting airlines, fashion, and alcohol consumption.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
GSK to Cut Up to 350 R&D Jobs in UK and US Restructuring
Pharmaceutical giant GSK is set to cut up to 350 research and development roles across its UK and US operations as part of a strategic overhaul of its R&D division.
GSK to Cut 350 R&D Jobs in US and UK
Pharmaceutical giant GSK announces up to 350 research and development job cuts across the US and UK, including approximately 50 positions at its Stevenage hub, as part of ongoing restructuring.
GSK Cuts 350 R&D Jobs in UK and US Restructuring
Pharmaceutical giant GSK is eliminating up to 350 research and development positions across the UK and United States as part of ongoing divisional restructuring, with around 50 UK jobs already affected at its Stevenage hub.
AstraZeneca Lists on NYSE in Strategic Market Move
UK pharmaceutical giant AstraZeneca has commenced trading on the New York Stock Exchange, delisting from Nasdaq as part of its global growth strategy targeting the US market.
Charities Appeal NHS Cancer Treatment Decision
Blood Cancer UK, Lymphoma Action and Anthony Nolan formally appeal against Nice's recommendation to remove Tecartus, a CAR T-cell therapy for mantle cell lymphoma, from NHS availability in England and Wales.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Gabapentin Users Warned: Five Symptoms Need Doctor Call
Patients taking the commonly prescribed medication gabapentin for nerve pain or epilepsy are being urged to contact a doctor immediately if they develop any of five specific serious symptoms.
GLP-1 Drugs Reshaping Food, Fashion & Travel Industries
Weight loss medications like Ozempic and Wegovy are causing seismic shifts across multiple sectors, reducing food and alcohol spending while impacting airlines, fashion, and fitness markets.
MHRA Warning: Pancreatitis Risk with Ozempic, Wegovy, Mounjaro
Medical regulators urge vigilance for rare but severe pancreatitis symptoms in patients using popular GLP-1 medications like Ozempic, Wegovy and Mounjaro across the UK.
Eli Lilly's $3.5bn Pennsylvania Plant for Drug Production
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing facility in Pennsylvania, expanding domestic production to meet soaring demand for its obesity and diabetes treatments.
NHS Amitriptyline Warning: Nine Groups Must Consult Doctors
The NHS advises nine specific groups to consult doctors before taking amitriptyline for pain relief, depression, or migraines. Key warnings include heart conditions, pregnancy, and medication interactions.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Peanut Allergy Drug Palforzia Pulled from Shelves
The only licensed immunotherapy for peanut allergy in young people is being discontinued globally, described as a commercial decision that leaves families without treatment options.
GLP-1 Drugs Linked to Pancreatitis Risk, MHRA Warns
The MHRA has updated safety information for Wegovy, Ozempic and Mounjaro to highlight a small but serious risk of severe acute pancreatitis, following a UK death linked to the medication.
AstraZeneca's £13.4bn Chinese Weight Loss Drug Deal
AstraZeneca announces a major £13.4 billion partnership with China's CSPC to develop monthly weight loss injections, aiming to challenge market leaders like Ozempic.
Trump: Eli Lilly Building Six New US Pharmaceutical Plants
Former President Donald Trump reveals pharmaceutical giant Eli Lilly plans to construct six new manufacturing facilities across the United States, expanding on previous investment announcements.
AstraZeneca's £11bn China Investment After UK Row
Britain's largest pharmaceutical firm AstraZeneca reveals a major $15bn investment in China during Keir Starmer's visit, months after scaling back UK expansion plans amid government disputes.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
UK Seizes £4m in Illegal Dermal Fillers
The MHRA has confiscated over 27,000 units of unlicensed dermal fillers since 2020, valued at up to £4 million, with a sharp rise in seizures in 2023.
Page 10 of 25
